These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19082251)

  • 1. [Pharmaceutical policies in Mexico: 20 years is nothing].
    Gasman N
    Salud Publica Mex; 2008; 50 Suppl 4():S423-6. PubMed ID: 19082251
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmaceuticals issue brief: pharmaceutical assistance programs: year end report--2004.
    Seay M
    Issue Brief Health Policy Track Serv; 2004 Dec; ():1-26. PubMed ID: 15724309
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmaceuticals: pharmaceutical assistance programs: year end report-2002.
    Kammer C
    Issue Brief Health Policy Track Serv; 2002 Dec; ():1-18. PubMed ID: 12856688
    [No Abstract]   [Full Text] [Related]  

  • 4. [Research to support pharmaceutical policies].
    Wirtz VJ; Reich MR; Hernández-Avila M
    Salud Publica Mex; 2008; 50 Suppl 4():S427-8. PubMed ID: 19082252
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of similar biotherapeutic products: scientific and regulatory challenges.
    Griffiths E; Thorpe R; Wadhwa M; Sohn Y
    Biologicals; 2011 Sep; 39(5):249. PubMed ID: 21925898
    [No Abstract]   [Full Text] [Related]  

  • 6. The politics of congressional health policy in the second half of the 1980s.
    Nexon D
    Med Care Rev; 1987; 44(1):65-88. PubMed ID: 10301638
    [No Abstract]   [Full Text] [Related]  

  • 7. Policies to improve access to pharmaceutical products in shortage: the experience of Iran food and drug administration.
    Yousefi N; Moradi N; Dinarvand R; Ghiasi G; Inanloo H; Peiravian F
    Daru; 2019 Jun; 27(1):169-177. PubMed ID: 30903556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharma 2020--An Economist Conference Shaping the Future of the Pharmaceuticals Industry.
    Kibble A
    IDrugs; 2008 May; 11(5):331-3. PubMed ID: 18465672
    [No Abstract]   [Full Text] [Related]  

  • 9. Prescription drug benefits for seniors and public/private collaboration.
    Brekke M
    Beginnings; 2002; 22(3):11. PubMed ID: 12046112
    [No Abstract]   [Full Text] [Related]  

  • 10. Patent highlights October-November 2017.
    Mucke HA
    Pharm Pat Anal; 2018 Mar; 7(2):73-81. PubMed ID: 29417883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WTO TRIPS and its effect on the supply and development of medicines in China.
    Tanner JA
    Hong Kong Med J; 2006 Feb; 12(1):84-6. PubMed ID: 16495599
    [No Abstract]   [Full Text] [Related]  

  • 12. Balancing government regulation against access to drugs: address to Seton Hall University School of Law, February 16, 2007.
    Meron D
    Seton Hall Law Rev; 2007; 37(4):929-39. PubMed ID: 18363219
    [No Abstract]   [Full Text] [Related]  

  • 13. The shape of European business in 2003.
    Wagner M
    Med Device Technol; 2002 Dec; 13(10):8-10. PubMed ID: 12575520
    [No Abstract]   [Full Text] [Related]  

  • 14. [Healthy pharmaceutical policy].
    González Pier E
    Salud Publica Mex; 2008; 50 Suppl 4():S488-95. PubMed ID: 19082260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congress, the FDA, and the fair development of new medications for children.
    McKinney RE
    Pediatrics; 2003 Sep; 112(3 Pt 1):669-70. PubMed ID: 12949299
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmaceutical Services and comprehensiveness 30 years after the advent of Brazil's Unified Health System.
    Bermudez JAZ; Esher A; Osorio-de-Castro CGS; Vasconcelos DMM; Chaves GC; Oliveira MA; Silva RMD; Luiza VL
    Cien Saude Colet; 2018 Jun; 23(6):1937-1949. PubMed ID: 29972501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mandated coverage: labor activity.
    Ignagni K
    Rep Natl Forum Hosp Health Aff; 1991; ():76-9; discussion 79-81, 100-7. PubMed ID: 10120222
    [No Abstract]   [Full Text] [Related]  

  • 18. New federal guidelines for physician-pharmaceutical industry relations: the politics of policy formation.
    Chimonas S; Rothman DJ
    Health Aff (Millwood); 2005; 24(4):949-60. PubMed ID: 16136634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug reimbursement policies in Canada--need for improved access to critical therapies.
    LeLorier J; Bell A; Bougher DJ; Cox JL; Turpie AG
    Ann Pharmacother; 2008 Jun; 42(6):869-73. PubMed ID: 18477735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Questions raised about whether compulsory licenses get best prices.
    Owens B
    Nat Med; 2015 Apr; 21(4):300. PubMed ID: 25849264
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.